Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2014
04/09/2014CN102453074B Pentacyclic triterpene saponin and application thereof
04/09/2014CN102441059B Ginseng chrysanthemum-prepared health-care sucking product capable of strengthening immunity
04/09/2014CN102408433B Pyrimidine-containing oximes, preparation method and applications thereof
04/09/2014CN102391180B Sulfydryl-containing tacrine derivative and preparation method and application thereof
04/09/2014CN102372673B Blonanserin crystallization and preparation method thereof
04/09/2014CN102367277B Polymer conjugates of mutated neublastin
04/09/2014CN102285948B 4-hydroxy-benzopyranone derivates and application thereof
04/09/2014CN102247436B Preparation method of Qingxuanpian
04/09/2014CN102241646B Hexenone compound, and medical purpose thereof
04/09/2014CN102105475B Spiroaminodihydrothiazine derivatives
04/09/2014CN102076222B Composition comprising carbohydrates and peptides which comprise tryptophan
04/09/2014CN102066357B Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
04/09/2014CN102046620B Benzothiophene oxide derivative and salt thereof
04/09/2014CN101955440B Crystal form of agomelatine and preparation method thereof
04/09/2014CN101657201B Neuroblast proliferation promoter and neurite outgrowth promoter
04/09/2014CN101443314B Aminoquinolones as GSK-3 inhibitors
04/09/2014CN101263119B 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity
04/08/2014US8691875 Solid forms of tacedinaline
04/08/2014US8691864 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
04/08/2014US8691849 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
04/08/2014US8691848 Inhibitors of caspases
04/08/2014US8691814 Deazapurines and uses thereof
04/08/2014US8691768 Methods of determining delta opioid receptor subtypes
04/08/2014US8691767 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses
04/08/2014US8691765 Metallothionein based neuronal therapeutic and therapeutic methods
04/08/2014US8691760 Peptides, pharmaceutical compositions comprising same and uses thereof
04/08/2014US8691216 Methods of using regenerative cells to promote wound healing
04/08/2014US8691185 Benzothiazole derivative compounds, compositions and uses
04/08/2014CA2782469C Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
04/08/2014CA2780040C 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
04/08/2014CA2771885C 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands
04/08/2014CA2653827C Novel blonanserin tape preparation
04/08/2014CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/08/2014CA2615533C Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic
04/08/2014CA2572047C Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof
04/08/2014CA2447576C Use of hmg fragment as anti-inflammatory agents
04/04/2014CA2800083A1 Integrated neuromodulation system for mood enhancement of a living human subject
04/03/2014WO2014052933A1 Laquinimod and pridopidine for treating neurodegenerative disorders
04/03/2014WO2014052896A1 Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
04/03/2014WO2014052859A1 Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
04/03/2014WO2014052849A1 Combination treatments for bipolar disorders
04/03/2014WO2014052837A1 Device and methods for sustained release of antipsychotic medications
04/03/2014WO2014052807A1 Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions
04/03/2014WO2014052789A1 Aav vectors targeted to oligodendrocytes
04/03/2014WO2014052766A1 Hepatocyte growth factor mimics as therapeutic agents
04/03/2014WO2014052669A1 Modulation of ire1
04/03/2014WO2014052659A1 Crystalline forms of neurotrophin mimetic compounds and their salts
04/03/2014WO2014052461A1 Treatment of central nervous system (cns) injury
04/03/2014WO2014052427A1 D-methadone for the treatment of psychiatric symptoms
04/03/2014WO2014052398A1 Inhibitor of beta-secretase
04/03/2014WO2014052394A1 Combination methods and compositions including sleep therapeutics for treating mood
04/03/2014WO2014051567A1 Chimeric neuregulins and method of making and use thereof
04/03/2014WO2014051388A1 Composition comprising sulfamide derivative having adamantyl group as active ingredient for preventing or treating brain diseases or ischemic heart diseases
04/03/2014WO2014051056A1 Crystals of glycine derivative and pharmaceutical use thereof
04/03/2014WO2014050779A1 Combination of gsk3 inhibitor and anti-dr5 antibody
04/03/2014WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same
04/03/2014WO2014050003A1 Expression modulator for clock gene period
04/03/2014WO2014049471A1 Compositions and methods for the treatment of ventricular arrhythmias and cardiovascular diseases
04/03/2014WO2014049366A1 Treatment of wolfram syndrome-related neurodegeneration
04/03/2014WO2014049133A1 New positive allosteric modulators of nicotinic acetylcholine receptor
04/03/2014WO2014048945A1 Bet protein-inhibiting 5-aryl triazole azepines
04/03/2014WO2014048865A1 New bicyclic derivatives
04/03/2014WO2014048380A1 Preparation method of agomelatine solid preparation
04/03/2014WO2014048370A1 Compositions and methods of treating and preventing neuronal damage from traumatic brain injury
04/03/2014WO2014048165A1 Compound as potassium channel modulator
04/03/2014WO2014048071A1 Method and pharmaceutical composition for inhibiting pi3k/akt/mtor signal path
04/03/2014WO2014048033A1 Polymorphs of cddo ethyl ester and uses thereof
04/03/2014WO2014047707A1 Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic pain
04/03/2014WO2014013338A3 Compounds for the treatment of alzheimer's disease
04/03/2014WO2014013090A3 Formulation comprising amorphous fingolimod
04/03/2014US20140093539 Protein a compositions and methods of use
04/02/2014EP2712615A1 Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia
04/02/2014CN1946395B 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
04/02/2014CN103703008A (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
04/02/2014CN103702983A Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
04/02/2014CN103702682A Compositions and methods for the treatment of neuromyelitis optica
04/02/2014CN103702680A Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
04/02/2014CN103702676A Chicory for prevention and treatment of neurodegeneration
04/02/2014CN103702669A Compounds for treating peripheral neuropathies and other neurodegenerative disorders
04/02/2014CN103695497A Enzymatic preparation of naloxone and pharmaceutical composition thereof
04/02/2014CN103694340A Recombinant protein IGF (insulin-like growth factor) 1-24 and application thereof
04/02/2014CN103694233A Benzisoxazole compound and application thereof
04/02/2014CN103694163A Compounds capable of being adopted as potassium channel modulators
04/02/2014CN103690984A Traditional Chinese medicine deodorizing air purifying agent and preparation method thereof
04/02/2014CN103690931A Preparation method and medical application of antipyretic-analgesic and anti-inflammatory part in Polybia spp. insects
04/02/2014CN103690926A Application of medlar polysaccharide to resistance to sleep deprivation stress damage
04/02/2014CN103690882A Traditional Chinese medicine granule for treating cerebral infarction sequela and preparation method thereof
04/02/2014CN103690878A Traditional Chinese medicine formula for caring and treating stomach and liver
04/02/2014CN103690857A Herbal medicine footbath powder for treating rheumatism
04/02/2014CN103690806A External application medicament for treating facial paralysis and preparation and use methods thereof
04/02/2014CN103690796A Traditional Chinese medicine for treating heart disease with syndrome of hyperactivity of heart fire
04/02/2014CN103690786A Traditional Chinese medicine for treating post-hepatitis syndrome
04/02/2014CN103690780A Heart-invigorating and sedative pill and preparation method thereof
04/02/2014CN103690769A Traditional Chinese medicine composition with function of tranquilizing mind by nourishing heart and preparation method of traditional Chinese medicine composition
04/02/2014CN103690765A Nerve calming and sleep aiding oral liquid and preparation method thereof
04/02/2014CN103690760A Traditional Chinese medicine composition for treating facial paralysis and preparation method thereof
04/02/2014CN103690735A Lemai pill composition
04/02/2014CN103690723A Medicament for treating apoplexy
04/02/2014CN103690719A Traditional Chinese medicine composition for treating intractable insomnia
04/02/2014CN103690708A External traditional Chinese medicinal foot bathing agent for warming and smoothing foot blood vessels
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 1833